Skip to Main Content

Paper Details

Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice.
Cell Rep Med
16
2021
4-1BB, B16 melanoma tumors, CD80, CTLA4, DCs, Dendritic cells, EL4 and A20 lymphomas, IPr, LAG3, MSC, MSC-IPr, MSCs, PD-1, cancer, immunoproteasome, immunoproteasome-expressing mesenchymal stromal cells, interleukin-12, lymphoma, major histocompatibility complex class I, melanoma, mesenchymal stromal cells, mice, non-hematopoietic antigen-presenting cells, tumors
Author NameAffiliation
Nehme El-HachemUniversite de Montreal
Nehme El-HachemUniversite de Montreal
Moutih RafeiMcGill University
Moutih RafeiUniversite de Montreal
Moutih RafeiUniversite de Montreal
Moutih RafeiUniversite de Montreal
  • 1 - 6

Datasets

Release 1.2